This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Activity Details

408 * Tue, 8/3/2010, 2:00 PM - 3:50 PM CC-222 (West)
Adaptive Designs — Contributed Papers
Biopharmaceutical Section
Chair(s): Katherine Monti, Rho, Inc.
2:05 PM Optimal Phase II Decision Rules in a Seamless PhaseII/III Clinical Trial Bo Jin, Merck Research Laboratories
2:20 PM Overall FDR Control in a Two-Stage Adaptive Design Jingjing Chen, Temple University ; Sanat K. Sarkar, Temple University
2:35 PM Generalized Hypothesis Testing in Interim Treatment Selection with a Flexible Selection Margin Yujun Wu, Sanofi-Aventis ; Peng-Liang Zhao, sanofi-aventis
2:50 PM Improving the Interim Analysis Process in Adaptive Design Trials — Xiaoyin Fan, Merck & Co., Inc. ; Mary Varughese, Merck & Co., Inc.
3:05 PM Interval Estimation in Two-Stage, Drop-the-Losers Clinical Trials with Flexible Treatment Selection Dan Neal, University of Florida ; George Casella, University of Florida ; Mark Yang, University of Florida ; Samuel S. Wu, University of Florida
3:20 PM Confidence Intervals for the Selected Treatment Effect in Multistage Adaptive Designs Ionut Bebu, Georgetown University Medical Center ; Vladimir Dragalin, Pfizer Inc. ; George Luta, Georgetown University
3:35 PM Floor Discussion

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.